1J5 — Hyphens Pharma International Share Price
Last trade - 00:00- SG$95.72m
- SG$84.43m
- SG$125.88m
- 90
- 52
- 97
- 96
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 11.37 | ||
| PEG Ratio (f) | 1.18 | ||
| EPS Growth (f) | 10.63% | ||
| Dividend Yield (f) | 2.58% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.75 | ||
| Price to Tang. Book | 2.78 | ||
| Price to Free Cashflow | 18.4 | ||
| Price to Sales | 0.76 | ||
| EV to EBITDA | 7.53 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 16.17% | ||
| Return on Equity | 13.45% | ||
| Operating Margin | 7.17% | ||
Financial Summary
| Year End 31st Dec | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SG$m | 112.65 | 120.93 | 119.44 | 123.7 | 125.88 | 145 | 151.4 | 4.51% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +10.88 | -18.21 | +4.87 | -11.4 | +15.87 | +16.38 | +7.69 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health Trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Hyphens Pharma International Limited is a Singapore-based specialty pharmaceutical and consumer healthcare company. The Company's principal activities are those of an investment holding company and provision of management services. The Company's segments include specialty pharma principals, proprietary brands, and medical hypermart and digital. The specialty pharma principals segment is engaged in the business of marketing and selling a range of specialty pharmaceutical products with exclusivity in the relevant ASEAN countries. The proprietary brands segment is engaged in the business of developing, marketing and selling its own proprietary range of dermatological products and health supplement products. The medical hypermart and digital segment is a wholesaler of pharmaceuticals and medical supplies in Singapore, which the Company and its subsidiaries position itself as a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies.
Directors
- Last Annual
- December 31st, 2021
- Last Interim
- December 31st, 2021
- Incorporated
- December 12th, 2017
- Public Since
- May 18th, 2018
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Singapore Exchange Securities Trading Ltd
- Shares in Issue
- 308,776,200
- Address
- 16 Tai Seng Street, Level 4, 534138
- Web
- https://www.hyphensgroup.com/
- Phone
- +65 62965751
- Auditors
- RSM Chio Lim
Upcoming Events for 1J5
Similar to 1J5
Haw Par
Singapore Exchange Securities Trading Ltd
IX Biopharma
Singapore Exchange Securities Trading Ltd
Pharmesis International
Singapore Exchange Securities Trading Ltd
Suntar Eco-City
Singapore Exchange Securities Trading Ltd
FAQ
As of Today at 01:10 UTC, shares in Hyphens Pharma International are trading at SG$0.31. This share price information is delayed by 15 minutes.
Shares in Hyphens Pharma International last closed at SG$0.31 and the price had moved by over the past 365 days. In terms of relative price strength the Hyphens Pharma International share price has outperformed the FTSE Developed Asia Pacific Index by +20.7% over the past year.
The overall consensus recommendation for Hyphens Pharma International is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Hyphens Pharma International dividend yield is 2.16% based on the trailing twelve month period.
Last year, Hyphens Pharma International paid a total dividend of SG$0.01, and it currently has a trailing dividend yield of 2.16%. We do not have any data on when Hyphens Pharma International is to next pay dividends.
We do not have data on when Hyphens Pharma International is to next pay dividends. The historic dividend yield on Hyphens Pharma International shares is currently 2.16%.
To buy shares in Hyphens Pharma International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SG$0.31, shares in Hyphens Pharma International had a market capitalisation of SG$95.72m.
Here are the trading details for Hyphens Pharma International:
- Country of listing: Singapore
- Exchange: SES
- Ticker Symbol: 1J5
Based on an overall assessment of its quality, value and momentum Hyphens Pharma International is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Hyphens Pharma International is SG$0.35. That is 13.87% above the last closing price of SG$0.31.
Analysts covering Hyphens Pharma International currently have a consensus Earnings Per Share (EPS) forecast of SG$0.03 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hyphens Pharma International. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +15.93%.
As of the last closing price of SG$0.31, shares in Hyphens Pharma International were trading +4.25% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Hyphens Pharma International PE ratio based on its reported earnings over the past 12 months is 11.37. The shares last closed at SG$0.31.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Hyphens Pharma International's directors